Back to the future: application of contemporary technology to long-standing questions about the clinical relevance of human leukocyte antigen-specific alloantibodies in renal transplantation
Authors:
- Craig J. TaylorCTCraig J. Taylor
- Vasilis KosmoliaptsisVKVasilis Kosmoliaptsis
- Dominic M. SummersDSDominic M. Summers
- J. Andrew BradleyJBJ. Andrew Bradley
- 1 August 2009
- journal article
- research article
- Published by Elsevier in Human Immunology
- Vol. 70 (8) , 563-568
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Solid phase testing in the HLA laboratory: implications for organ allocationInternational Journal of Immunogenetics, 2008
- The Importance of Anti-HLA-Specific Antibody Strength in Monitoring Kidney Transplant PatientsAmerican Journal of Transplantation, 2007
- Activated HLA class I-reactive cytotoxic T lymphocytes associated with a positive historical crossmatch predict early graft failure1Transplantation, 2002
- REJECTION OF A KIDNEY TRANSPLANT DOES NOT ALWAYS LEAD TO PRIMING OF CYTOTOXIC T CELLS AGAINST MISMATCHED DONOR HLA CLASS I ANTIGENS1Transplantation, 2001
- FLOW CYTOMETRY-DETECTED IgG IS NOT A CONTRAINDICATION TO RENAL TRANSPLANTATIONTransplantation, 1999
- Production and characterization of human monoclonal lymphocytotoxic autoantibodies from a renal dialysis patientTissue Antigens, 1991
- THE FLOW CYTOMETRIC CROSSMATCH AND EARLY RENAL TRANSPLANT LOSSTransplantation, 1990
- Successful transplantation with a positive T and B cell crossmatch due to autoreactive antibodiesTissue Antigens, 1983
- MOST POSITIVE B CELL CROSSMATCHES ARE NOT CAUSED BY ANTI-HLA-DR ANTIBODIESTransplantation, 1980
- AUTOLYMPHOCYTOTOXIC ANTIBODIES AND KIDNEY TRANSPLANTATIONThe Lancet, 1977